Unicet
Latest round
- Series A
Last raised
- Jun 2026
Total raised
- $30M
Investors
- 7
About Unicet
, trading as Unicet, is a biotech company that focuses on the development of cell drugs.d T cell/BTN immune mechanisms in the fields of cancer, infectious diseases and autoimmune diseases. The company generates revenue from the R&D of cell drugs.d T cell technology platform.
Who invested in Unicet
7 investors across 3 rounds
See all investors in Unicet
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Unicet
Who invested in Unicet?
Unicet has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Unicet raised?
Unicet has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Unicet last raise money?
Unicet's most recent round on record is a Series A, in Jun 2026.
What does Unicet do?
, trading as Unicet, is a biotech company that focuses on the development of cell drugs.
Where is Unicet headquartered?
Unicet is headquartered in Beijing, China.
Which VCs invest in companies like Unicet?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Unicet's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Unicet? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.